0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-06-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP SC625130 2024-06-01 2025-05-31 SC625130 2025-05-31 SC625130 2024-05-31 SC625130 2023-06-01 2024-05-31 SC625130 2024-05-31 SC625130 2023-05-31 SC625130 bus:Director1 2024-06-01 2025-05-31 SC625130 core:WithinOneYear 2025-05-31 SC625130 core:WithinOneYear 2024-05-31 SC625130 core:ShareCapital 2025-05-31 SC625130 core:ShareCapital 2024-05-31 SC625130 bus:SmallEntities 2024-06-01 2025-05-31 SC625130 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 SC625130 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 SC625130 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 SC625130 bus:FullAccounts 2024-06-01 2025-05-31
COMPANY REGISTRATION NUMBER: SC625130

Neurotherapy Services Limited

Filleted Unaudited Financial Statements

For the year ended

31 May 2025

Neurotherapy Services Limited

Statement of Financial Position

31 May 2025

| 2025 | 2024
Note | £ | £

Current assets

Debtors | 4 | 100 | 100
Cash at bank and in hand | 350,249 | 223,166
| --------- | ---------
| 350,349 | 223,266

Creditors: amounts falling due within one year | 5 | 350,249 | 223,166
| --------- | ---------
Net current assets | 100 | 100
| ---- | ----
Total assets less current liabilities | 100 | 100
| ---- | ----

Capital and reserves

Called up share capital | 100 | 100
| ---- | ----
Shareholder funds | 100 | 100
| ---- | ----

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 9 February 2026 , and are signed on behalf of the board by:

Mrs M S McGowan |
Director |

Company registration number: SC625130

Neurotherapy Services Limited

Notes to the Financial Statements

Year ended 31 May 2025
1. General information
The company is a private company limited by shares, registered in Scotland. The address of the registered office is Suite 62 4-5 Lochside Way, Edinburgh Park, Edinburgh, EH12 9DT.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
4. Debtors

| 2025 | 2024
| £ | £
Amounts owed by group undertakings and undertakings in which the company has a participating interest | 100 | 100
| ---- | ----

5. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Other creditors | 350,249 | 223,166
| --------- | ---------

6. Related party transactions
Control: The company was under the control of the director throughout the period under review. Transactions: No transactions with related parties were undertaken such as are required to be disclosed under Section 1A of FRS 102.
7. Controlling party
The ultimate parent undertaking of the company is Mar House Limited , a company registered in Scotland, which owns the entire issued share capital of the company.